News Release - February 7, 2008

New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy

Source: Tibotec Therapeutics

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.